How We Treat Left-Sided vs Right-Sided Colon Cancer

Diana L. Hanna, MD, and Heinz-Josef Lenz, MD, FACP

Learning Objectives • To understand the biological and clinical differences between left-sided and right-sided colon cancer; • To identify appropriate therapies for patients with metastatic […]

Providing Oncology Care During the COVID-19 Pandemic

Gary H. Lyman, MD, MPH

H&O What has it been like practicing oncology in Washington state over the past few months? GL Most of my insights are based on the […]

Strategies to Overcome Resistance to PD-1 Inhibitors

Thomas F. Gajewski, MD, PhD

H&O How do programmed death 1 (PD-1) inhibitors work? TG There is a growing list of antibodies that target either the PD-1 receptor or the ligand […]

Improving Outcomes With Checkpoint Blockade in Non-Hodgkin Lymphoma

Joshua Brody, MD

H&O How effective are standard treatments for non-Hodgkin lymphoma (NHL)? JB There are effective therapies for diffuse large B-cell lymphoma (DLBCL), which is the most […]

Advances in Borderline Resectable Pancreatic Adenocarcinoma

Deepak Vadehra, DO, Patrick N. Salibi, MD, Derek R. McHaffie, MD, Jesse Sulzer, MD, David A. Iannitti, MD, and Jimmy J. Hwang, MD

Abstract: Pancreatic adenocarcinoma is one of the most lethal cancers in oncology. Pancreatic cancer is the third most common cause of cancer-related mortality in the United […]

COVID-19 in HEM/ONC News

Devon Schuyler

Tocilizumab May Help Patients With COVID-19 and Myeloma The immunosuppressant tocilizumab (Actemra, Genentech) may be an effective treatment for severe coronavirus disease 2019 (COVID-19) in patients […]

Letter From the Editor

Letter From the Editor: Outside of Our Comfort Zone

Richard R. Furman, MD

I write this letter during a time of great stress, given the ongoing COVID-19 crisis. As an oncologist, I must confess that my situation is far less […]

Archive: May 2020

Colorectal Cancer